APA (7th ed.) Citation

A, K., L, C., S, X., R, V., H, Y., F, B., . . . SM, S. (2021). Global Phosphoproteomics Reveal CDK Suppression as a Vulnerability to KRas Addiction in Pancreatic Cancer. Clinical cancer research : an official journal of the American Association for Cancer Research, 27(14), 4012. https://doi.org/10.1158/1078-0432.CCR-20-4781

Chicago Style (17th ed.) Citation

A, Kazi, et al. "Global Phosphoproteomics Reveal CDK Suppression as a Vulnerability to KRas Addiction in Pancreatic Cancer." Clinical Cancer Research : An Official Journal of the American Association for Cancer Research 27, no. 14 (2021): 4012. https://doi.org/10.1158/1078-0432.CCR-20-4781.

MLA (9th ed.) Citation

A, Kazi, et al. "Global Phosphoproteomics Reveal CDK Suppression as a Vulnerability to KRas Addiction in Pancreatic Cancer." Clinical Cancer Research : An Official Journal of the American Association for Cancer Research, vol. 27, no. 14, 2021, p. 4012, https://doi.org/10.1158/1078-0432.CCR-20-4781.